Inventor · disambiguated record
David K. Leahy
Also filed as: LEAHY DAVID K · LEAHY DAVID KENNETH
11 granted patents·12 pending applications·114 citations·filing 2005–2025
90Inventor score
Files withBRISTOL MYERS SQUIBB CO13VIIV HEALTHCARE UK NO 4 LTD5LEAHY DAVID K2UEDA YASUTSUGU2BIOHAVEN THERAPEUTICS LTD1
Top patents by PatentIndex Score
23 records- 0197US7745625B2Prodrugs of piperazine and substituted piperidine antiviral agentsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Jun 29, 2010·62 cites·7 claims
- 0292US8168615B2Prodrugs of piperazine and substituted piperidine antiviral agentsUEDA YASUTSUGU·Filed 2010·Granted May 1, 2012·14 cites·1 claims
- 0391US8461333B2Salts of prodrugs of piperazine and substituted piperidine antiviral agentsUEDA YASUTSUGU·Filed 2012·Granted Jun 11, 2013·12 cites·2 claims
- 0488US8669368B2Process for the preparation of cycloheptapyridine CGRP receptor antagonistsLEAHY DAVID K·Filed 2011·Granted Mar 11, 2014·10 cites·3 claims
- 0587US8871771B2Salts of prodrugs of piperazine and substituted piperidine antiviral agentsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Oct 28, 2014·5 cites·1 claims
- 0682US7723338B2Crystalline forms of 1-benzoyl-4-[2-[4,7-dimethoxy-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-yl]-1,2-dioxoethyl]-piperazineBRISTOL MYERS SQUIBB CO·Filed 2006·Granted May 25, 2010·5 cites·12 claims
- 0777US8143403B2CGRP receptor antagonistsLEAHY DAVID K·Filed 2010·Granted Mar 27, 2012·3 cites·5 claims
- 0876US11369624B2Salts of prodrugs of piperazine and substituted piperidine antiviral agentsVIIV HEALTHCARE UK NO 4 LTD·Filed 2020·Granted Jun 28, 2022·0 cites·1 claims
- 0974US9718845B2Process for the preparation of cycloheptapyridine CGRP receptor antagonistsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Aug 1, 2017·1 cites·9 claims
- 1072US2020046743A1Salts of prodrugs of piperazine and substituted piperidine antiviral agentsVIIV HEALTHCARE UK NO 4 LTD·Filed 2019·Application pending·0 cites
- 1170US2019111066A1Salts of prodrugs of piperazine and substituted piperidine antiviral agentsVIIV HEALTHCARE UK NO 4 LTD·Filed 2018·Application pending·0 cites
- 1269US7671199B2Process for the preparation of [(1R), 2S]-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2, 1-F][1,2,4]triazin-6-yloxy]-1-methylethyl esterBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Mar 2, 2010·2 cites·16 claims
- 1367US2015025240A1Salts of prodrugs of piperazine and substituted piperidine antiviral agentsBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 1466US2018000849A1Salts of prodrugs of piperazine and substituted piperidine antiviral agentsVIIV HEALTHCARE UK (NO 4) LTD·Filed 2017·Application pending·0 cites
- 1564US2015099887A1Process for the preparation of cycloheptapyridine cgrp receptor antagonistsBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 1663US2016361328A1Salts of prodrugs of piperazine and substituted piperidine antiviral agentsVIIV HEALTHCARE UK (NO 4) LTD·Filed 2016·Application pending·0 cites
- 1762US2014135500A1Process for the Preparation of Cycloheptapyridine CGRP Receptor AntagonistsBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 1862US2022177482A1Process for the preparation of n-((1r,2s,5r)-5-(tert-butylamino)-2-((s)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamideBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 1961US2015315218A1Salts of prodrugs of piperazine and substituted piperidine antiviral agentsBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 2061US2015232414A1Salts of prodrugs of piperazine and substituted piperidine antiviral agentsBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 2157US2015361047A1Process for the Preparation of Cycloheptapyridine CGRP Receptor AntagonistsBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 2249US11254679B2Process for the preparation of N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrroldin-1-yl)cyclohexyl)acetamideBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Feb 22, 2022·0 cites·1 claims
- 2348US2025228957A1Bifunctional degraders of galactose-deficient immunoglobulinsBIOHAVEN THERAPEUTICS LTD·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David K. Leahy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →